Cow’s milk allergy (CMA) is one of the most common food allergies in infants and young children, and if not adequately managed, can adversely impact growth and development. Formulas based on rice milk (known as hydrolyzed rice protein-based formula) have shown promise as an alternative to cow’s milk formula.
Meridian is now enrolling participants for a study of an investigational hydrolyzed rice-protein based formula for infants with persistent feeding intolerance symptoms, symptoms of suspected food protein allergy (milk and/or soy), or who are currently consuming an extensively hydrolyzed formula (EHF).
- Must be 0-90 days old
- Must be either: 1) experiencing symptoms of suspected food protein allergy (including diarrhea, constipation, vomiting, and/or spit up) OR 2) currently consuming an EHF (Alimentum© or Nutramigen©, or another commercially available EHF on the market) for a suspected food protein allergy or other feeding intolerance symptoms
- Will receive infant formula at no cost throughout this study.
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for your child.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Submit your information
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.